Abstract
Neuropsychology traditionally studies the effect of neurological diseases, such as stroke and dementia, on cognitive functioning. The focus on non-neurological diseases, including diabetes, has grown over the last decades. In this chapter we summarize the current literature with respect to cognitive functioning in patients with type 1 and type 2 diabetes. Both types of diabetes seem to affect similar cognitive domains with similar effect sizes. Risk factors largely pertain to the effects of chronic hyperglycemic exposure, macrovascular comorbidity, and psychiatric conditions. With the rapidly increasing prevalence of diabetes and life expectancy, the development of dementia is important to take into account. We therefore discuss the current understanding of the relationship between diabetes and dementia and how antidiabetic medication may have a protective effect. In the last sections, we will detail the clinical relevance of cognitive decrements found in studies and what we think are the most important future questions to be answered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramovitch, A., Mittelman, A., Tankersley, A. P., Abramowitz, J. S., & Schweiger, A. (2015). Neuropsychological investigations in obsessive-compulsive disorder: A systematic review of methodological challenges. Psychiatry Research, 228(1), 112–120.
Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., … Kivipelto, M. (2010). Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology, 75(13), 1195–1202.
Awad, N., Gagnon, M., & Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26(8), 1044–1080.
Biessels, G. J., Deary, I. J., & Ryan, C. M. (2008). Cognition and diabetes: A lifespan perspective. Lancet Neurology, 7(2), 184–190.
Brands, A. M., Biessels, G. J., de Haan, E. H., Kappelle, L. J., & Kessels, R. P. (2005). The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care, 28(3), 726–735.
Brands, A. M., Kessels, R. P., Hoogma, R. P., Henselmans, J. M., van der Beek Boter, J. W., Kappelle, L. J., … Biessels, G. J. (2006). Cognitive performance, psychological Well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes, 55(6), 1800–1806.
Brands, A. M., van den Berg, E., Manschot, S. M., Biessels, G. J., Kappelle, J. L., de Haan, E. H., & Kessels, R. P. (2007a). A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. Journal of the International Neuropsychological Society, 13, 288–297.
Brands, A. M. A., Biessels, G. J., Kappelle, L. J., de Haan, E. H. F., de Valk, H. W., Algra, A., & Kessels, R. P. C. (2007b). Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: A comparative study. Dementia and Geriatric Cognitive Disorders, 23, 343–350.
Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813–820.
Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54, 1615–1625.
Bruehl, H., Wolf, O. T., Sweat, V., Tirsi, A., Richardson, S., & Convit, A. (2009). Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Research, 1280, 186–194.
Cheng, G., Huang, C., Deng, H., & Wang, H. (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Internal Medicine Journal, 42(5), 484–491.
Chung, C. C., Pimentel, D., Jordan, A. J., Hao, Y., Milberg, W., & Novak, V. (2015). Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology, 85, 1–9.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
Cox, D. J., Kovatchev, B. P., Anderson, S. M., Clarke, W. L., & Gonder-Frederick, L. A. (2010). Type 1 diabetic drivers with and without a history of recurrent hypoglycemia–related driving mishaps. Diabetes Care, 33(11), 2430–2435.
De Jong, R. (1950). The nervous system complications in diabetes mellitus with special reference to cerebrovascular changes. The Journal of Nervous and Mental Disease, 111, 181–206.
Domínguez, R. O., Marschoff, E. R., González, S. E., Repetto, M. G., & Serra, J. A. (2012). Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer’s disease patients. Diabetes Research and Clinical Practice, 98(1), 68–74.
Exalto, L. G., Biessels, G. J., Karter, A. J., Huang, E. S., Katon, W. J., Minkoff, J. R., & Whitmer, R. A. (2013). Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study. The Lancet Diabetes and Endocrinology. https://doi.org/10.1016/S2213-8587(1013)70048-70042. Epub ahead of print.
Foundation WID. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of the WHO/IDF consultation. Geneva, Switzerland: World Health Organization.
Guerrero-Berroa, E., Schmeidler, J., & Beeri, M. S. (2014). Neuropathology of type 2 diabetes: A short review on insulin-related mechanisms. European Neuropsychopharmacology, 24(12), 1961–1966.
Harada, C. N., Natelson Love, M. C., & Triebel, K. L. (2013). Normal cognitive aging. Clinics in Geriatric Medicine, 29, 737–752.
Hsu, C. C., Wahlqvist, M. L., Lee, M. S., & Tsai, H. N. (2011). Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. Journal of Alzheimer’s Disease, 24(3), 485–493.
Hugenschmidt, C. E., Lovato, J. F., Ambrosius, W. T., Bryan, R. N., Gerstein, H. C., Horowitz, K. R., … Ding, J. (2014). The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care, 37, 3244–3252.
Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012). Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: A population-based case–control study. Journal of the American Geriatrics Society, 60(5), 916–921.
Katon, W., Pedersen, H., Ribe, A., Fenger-Grøn, M., Davydow, D., Boch Waldorff, F., & Vestergaard, M. (2015). Effect of depression and diabetes mellitus on the risk for dementia: A national population-based cohort study. JAMA Psychiatry, 72(6), 612–619.
Kester, M. I., van der Flier, W. M., Mandic, G., Blankenstein, M. A., Scheltens, P., & Muller, M. (2010). Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer’s disease. Journal of Alzheimer's Disease, 20(4), 1083–1090.
Lezak, M. D. (2012). Neuropsychological assessment. Oxford: Oxford University Press.
Lin, E. H., Rutter, C. M., Katon, W., Heckbert, S. R., Ciechanowski, P., Oliver, M. M., … Von Korff, M. (2010). Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care, 33, 264–269.
Luchsinger, J. A., Palmas, W., Teresi, J. A., Silver, S., Kong, J., Eimicke, J. P., … Shea, S. (2011). Improved diabetes control in the elderly delays global cognitive decline. The Journal of Nutrition, Health & Aging, 15(6), 445–449.
Miles, W. R., & Root, H. F. (1922). Psychologic tests applied to diabetic patients. Archives of Internal Medicine, 30(6), 767–777.
Musen, G., Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., … T. D. E. R. Group. (2008). The impact of diabetes and its treatment on cognitive function among adolescents who participated in the DCCT. Diabetes Care, 31, 1933–1938.
Nelson, P. T., Smith, C. D., Abner, E. A., Schmitt, F. A., Scheff, S. W., Davis, G. J., … Markesbery, W. R. (2009). Human cerebral neuropathology of type 2 diabetes mellitus. Biochimica et Biophysica Acta, 1792, 454–469.
Northam, E. A., Anderson, P. J., Werther, G. A., Warne, G. L., Adler, R. G., & Andrewes, D. (1998). Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care, 21, 379–384.
Ouwens, D. M., van Duinkerken, E., Schoonenboom, S. N. M., Herzfeld de Wiza, D., Klein, M., van Golen, L., … Diamant, M. (2014). Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes. Diabetologia, 57, 2208–2214.
Palta, P., Schneider, A. L. C., Biessels, G. J., Touradji, P., & Hill-Briggs, F. (2014). Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. Journal of International Neurpsychological Society, 20, 278–291.
Patiño-Fernández, A. M., Delamater, A. M., Applegate, E. B., Brady, E., Eidson, M., Nemery, R., … Richton, S. (2010). Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes, 11, 424–430.
Patrone, C., Eriksson, O., & Lindholm, D. (2014). Diabetes drugs and neurological disorders: New views and therapeutic possibilities. The Lancet Diabetes and Endocrinology, 2(3), 256–262.
Reske-Nielsen, E., & Lundbæk, K. (1968). Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia, 4(1), 34–43.
Reske-Nielsen, E., Lundbæk, K., & Rafaelsen, O. J. (1966). Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia, 1(3), 233–241.
Roberts, R. O., Knopman, D. S., Przybelski, S. A., Mielke, M. M., Kantarci, K., Preboske, G. M., … Jack, C. R. J. (2014). Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology, 82, 1132–1141.
Roriz-Filho, J. S., Sá-Roriz, T. M., Rosset, I., Camozzato, A. L., Santos, A. C., Chaves, M. L. F., … Roriz-Cruz, M. (2009). (Pre)diabetes, brain aging, and cognition. Biochimica et Biophysica Acta, 1792(5), 432–443.
Roy, S., Kim, N., Desai, A., Komaragiri, M., Baxi, N., Jassil, N., … Hunter, K. (2015). Cognitive function and control of type 2 diabetes mellitus in young adults. North American Journal of Medical Sciences, 7, 220–226.
Ryan, C. (2006). Diabetes and brain damage: More (or less) than meets the eye? Diabetologia, 49(10), 2229–2233.
Ryan, C. M., Geckle, M. O., & Orchard, T. J. (2003). Cognitive efficiency declines over time in adults with type 1 diabetes: Effects of micro- and macrovascular complications. Diabetologia, 46(7), 940–948.
Smolina, K., Wotton, C. J., & Goldacre, M. J. (2015). Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998–2011: A retrospective national record linkage cohort study. Diabetologia, 58, 942–950.
Snoek, F. J., Bremmer, M. A., & Hermanns, N. (2015). Constructs of depression and distress in diabetes: Time for an appraisal. The Lancet Diabetes and Endocrinology, 3, 450–460.
Sonnen, J. A., Larson, E. B., Brickell, K., et al. (2009). Different patterns of cerebral injury in dementia with or without diabetes. Archives of Neurology, 66(3), 315–322.
Spauwen, P. J. J., Köhler, S., Verhey, F. R. J., Stehouwer, C. D. A., & van Boxtel, M. P. J. (2013). Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study. Diabetes Care, 36, 1554–1561.
Sullivan, M. D., Katon, W. J., Lovato, L. C., Miller, M. E., Murray, A. M., Horowitz, K. R., … Launer, L. J. (2013). Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the accord-mind trial. JAMA Psychiatry, 70, 1041–1047.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. (2007). Long-term effect of diabetes and its treatment on cognitive function. The New England Journal of Medicine, 356(18), 1842–1852.
Tonoli, C., Heyman, E., Roelands, B., Pattyn, N., Buyse, L., Piacentini, M. F., … Meeusen, R. (2014). Type 1 diabetes-associated cognitive decline: A meta-analysis and update of the current literature 1型糖尿病相关的认知能力下降:一项对最新文献的meta分析. Journal of Diabetes, 6, 499–513.
Tuligenga, R. H., Dugravot, A., Tabák, A. G., Elbaz, A., Brunner, E. J., Kivimäki, M., & Singh-Manoux, A. (2014). Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: A post-hoc analysis of the Whitehall II cohort study. The Lancet Diabetes and Endocrinology, 2(3), 228–235.
van den Berg, E., Biessels, G. J., de Craen, A. J. M., Gussekloo, J., & Westendorp, R. G. J. (2007). The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology, 69(10), 979–985.
van den Berg, E., de Craen, A., Biessels, G., Gussekloo, J., & Westendorp, R. (2006). The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia, 49(9), 2015–2023.
van den Berg, E., Dekker, J. M., Nijpels, G., Kessels, R. P., Kappelle, L. J., de Haan, E. H., … Biessels, G. J. (2008). Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dementia and Geriatric Cognitive Disorders, 26(3), 261–269.
van den Berg, E., Kloppenborg, R. P., Kessels, R. P. C., Kappelle, L. J., & Biessels, G. J. (2009). Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochimica et Biophysica Acta, 1792, 470–481.
van den Berg, E., Reijmer, Y., de Bresser, J., Kessels, R., Kappelle, L., Biessels, G., & and on behalf of the Utrecht Diabetic Encephalopathy Study. (2010). A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia, 53(1), 58–65.
van Dooren, F. E., Nefs, G., Schram, M. T., Verhey, F. R. J., Denollet, J., & Pouwer, F. (2013). Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLoS One, 8, e57058. https://doi.org/10.1371/journal.pone.0057058.
van Duinkerken, E., Brands, A. M. A., van den Berg, E., Henselmans, J. M. L., Hoogma, R. P. L. M., Biessels, G. J., & On behalf of the Utrecht Diabetic Encephalopathy Study Group. (2011). Cognition in older patients with type 1 diabetes mellitus: A longitudinal study. Journal of the American Geriatrics Society, 59, 563–565.
van Duinkerken, E., Schoonheim, M. M., Sanz-Arigita, E. J., IJzerman, R. G., Moll, A. C., Snoek, F. J., … Barkhof, F. (2012). Resting-state brain networks in type 1 diabetes patients with and without microangiopathy and their relation with cognitive functions and disease variables. Diabetes, 61, 1814–1821.
Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., … Craft, S. (2003). Insulin increases CSF Ab42 levels in normal older adults. Neurology, 60(12), 1899–1903.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
van Duinkerken, E., Brands, A.M.A. (2020). Neurocognitive Functioning in Type 1 and Type 2 Diabetes Mellitus. In: Delamater, A., Marrero, D. (eds) Behavioral Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-33286-0_23
Download citation
DOI: https://doi.org/10.1007/978-3-030-33286-0_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33284-6
Online ISBN: 978-3-030-33286-0
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)